Chris Ashwood
@cashwood.proteaglyco.com
Director of Protea Glycosciences
Accelerating glycoscience research
Accelerating glycoscience research
Pinned
Chris Ashwood
@cashwood.proteaglyco.com
· Nov 21
Given the influx of people at bsky, thought I would formally introduce myself 👋
I'm Chris, an Australian glycoscientist who has studied the field for >10 years now (across both AU and US), starting (MRes and PhD) in the lab of Prof. Nicki Packer.
I believe LC-MS glyco still has a lot to discover.
I'm Chris, an Australian glycoscientist who has studied the field for >10 years now (across both AU and US), starting (MRes and PhD) in the lab of Prof. Nicki Packer.
I believe LC-MS glyco still has a lot to discover.
Reposted by Chris Ashwood
May Institute on Computation & Statistics for MS and Proteomics is taking great shape. Fantastic new and repeat instructors and lots of new content. We are grateful to our sponsors Fragmatics and Biognosys. Keep an eye on the website computationalproteomics.khoury.northeastern.edu
November 10, 2025 at 4:39 PM
May Institute on Computation & Statistics for MS and Proteomics is taking great shape. Fantastic new and repeat instructors and lots of new content. We are grateful to our sponsors Fragmatics and Biognosys. Keep an eye on the website computationalproteomics.khoury.northeastern.edu
Reposted by Chris Ashwood
A few weeks ago I attended the Olympic Peninsula Fungi Festival. I went as someone who is interested in most everything in the world, lives in a wet, fungi filled temperate rainforest, and is mostly ignorant about fungi. Here are some things I learned:
November 11, 2025 at 2:58 AM
A few weeks ago I attended the Olympic Peninsula Fungi Festival. I went as someone who is interested in most everything in the world, lives in a wet, fungi filled temperate rainforest, and is mostly ignorant about fungi. Here are some things I learned:
Reposted by Chris Ashwood
"I have lost count of the number of times over the years that I’ve said “Huh, I didn’t think mass spec could do that”."
Mass spec ID after screening hundreds of thousands of mixed library compounds - without any sort of tagging or labeling? Yikes:
Screening Without Tagging
www.science.org
November 10, 2025 at 10:52 PM
"I have lost count of the number of times over the years that I’ve said “Huh, I didn’t think mass spec could do that”."
Reposted by Chris Ashwood
B4GALT1 and Wntless collaborate to block LRP5/6 translocation from #Golgi to cell surface, say Xinyang Li, Yue Hua, Xiaoqing Gan and colleagues (Fudan University): rupress.org/jcb/article/...
#Biochemistry #Trafficking #CellSignaling #Wnt
#Biochemistry #Trafficking #CellSignaling #Wnt
November 10, 2025 at 7:45 PM
B4GALT1 and Wntless collaborate to block LRP5/6 translocation from #Golgi to cell surface, say Xinyang Li, Yue Hua, Xiaoqing Gan and colleagues (Fudan University): rupress.org/jcb/article/...
#Biochemistry #Trafficking #CellSignaling #Wnt
#Biochemistry #Trafficking #CellSignaling #Wnt
To use it, it's best to search for the instrument model and work from there.
Here's an example of all Orbitrap Astral (Zoom) tenders with purchase values:
The $1 is likely a placeholder, but MPI may not be.
These can also include LC, service contracts, etc, so approximation at best
Here's an example of all Orbitrap Astral (Zoom) tenders with purchase values:
The $1 is likely a placeholder, but MPI may not be.
These can also include LC, service contracts, etc, so approximation at best
November 10, 2025 at 12:21 PM
To use it, it's best to search for the instrument model and work from there.
Here's an example of all Orbitrap Astral (Zoom) tenders with purchase values:
The $1 is likely a placeholder, but MPI may not be.
These can also include LC, service contracts, etc, so approximation at best
Here's an example of all Orbitrap Astral (Zoom) tenders with purchase values:
The $1 is likely a placeholder, but MPI may not be.
These can also include LC, service contracts, etc, so approximation at best
That’s been the main goal with leaks and posting instrument prices, more informed MS purchases.
The more informed the purchases are, the better value for money these funding bodies (and labs) get.
The more informed the purchases are, the better value for money these funding bodies (and labs) get.
November 10, 2025 at 7:59 AM
That’s been the main goal with leaks and posting instrument prices, more informed MS purchases.
The more informed the purchases are, the better value for money these funding bodies (and labs) get.
The more informed the purchases are, the better value for money these funding bodies (and labs) get.
I've just come across a resource for finding MS prices beyond the US (GSA Advantage).
It's called EU Tenders (ted.europa.eu) and has many recent MS prices on there.
E.g. Astral Zoom with FAIMS Pro Duo is listed as $1.75 million Euro ($2 million USD)
Limited info but probably includes an unlisted LC
It's called EU Tenders (ted.europa.eu) and has many recent MS prices on there.
E.g. Astral Zoom with FAIMS Pro Duo is listed as $1.75 million Euro ($2 million USD)
Limited info but probably includes an unlisted LC
TED - EU Tenders, the Supplement to the Official Journal - TED - Liferay DXP
Homepage of the official portal of TED, Tenders Electronic Daily. TED contains all active notices published in the Supplement to the EU Official Journal.
ted.europa.eu
November 10, 2025 at 1:05 AM
I've just come across a resource for finding MS prices beyond the US (GSA Advantage).
It's called EU Tenders (ted.europa.eu) and has many recent MS prices on there.
E.g. Astral Zoom with FAIMS Pro Duo is listed as $1.75 million Euro ($2 million USD)
Limited info but probably includes an unlisted LC
It's called EU Tenders (ted.europa.eu) and has many recent MS prices on there.
E.g. Astral Zoom with FAIMS Pro Duo is listed as $1.75 million Euro ($2 million USD)
Limited info but probably includes an unlisted LC
Reposted by Chris Ashwood
This is due to training cut-offs, and because in human review, manuscripts are compared against the reviewers accumulated experience, which is not primarily stored in a textual format that is publicly accessible for the LLM to use. This argues against using centralised LLMs for peer review.
November 8, 2025 at 4:46 AM
This is due to training cut-offs, and because in human review, manuscripts are compared against the reviewers accumulated experience, which is not primarily stored in a textual format that is publicly accessible for the LLM to use. This argues against using centralised LLMs for peer review.
Reposted by Chris Ashwood
My personal experience, and anecdotes from friends, agreed with these observations.
For the last 3 years, the story of the biotech financing environment has been much the same. Venture funding is slow, IPOs are few and far between. Mergers and acquisitions are beginning to pick up, but they tend to be smaller transactions: cen.acs.org/business/fin... #chemsky 🧪
Biotech markets aren't picking up just yet
Despite some recent eye-catching deals, the financing environment is still sluggish
cen.acs.org
November 7, 2025 at 10:05 PM
My personal experience, and anecdotes from friends, agreed with these observations.
Reposted by Chris Ashwood
Fun day out at Waters charge detection mass spectrometry (CD-MS) technology day.
November 6, 2025 at 7:14 PM
Fun day out at Waters charge detection mass spectrometry (CD-MS) technology day.
New TMT Tribrid from Thermo for #ASMS2026 (public info)
- IRMPD is the new UPVD
- IRMPD with TMT boosts reporter intensity by up to 240% without affecting quant
- New resolutions -> Down to 1k res, with an associated loss of signal, but at least it looks faster!
- Improved proton transfer reaction
- IRMPD is the new UPVD
- IRMPD with TMT boosts reporter intensity by up to 240% without affecting quant
- New resolutions -> Down to 1k res, with an associated loss of signal, but at least it looks faster!
- Improved proton transfer reaction
November 6, 2025 at 7:18 AM
New TMT Tribrid from Thermo for #ASMS2026 (public info)
- IRMPD is the new UPVD
- IRMPD with TMT boosts reporter intensity by up to 240% without affecting quant
- New resolutions -> Down to 1k res, with an associated loss of signal, but at least it looks faster!
- Improved proton transfer reaction
- IRMPD is the new UPVD
- IRMPD with TMT boosts reporter intensity by up to 240% without affecting quant
- New resolutions -> Down to 1k res, with an associated loss of signal, but at least it looks faster!
- Improved proton transfer reaction
Reposted by Chris Ashwood
My student's paper on enzymatic remodelling to generate anionic glycan arrays has just been published online in @jbiolchem! Various recombinant glycosyl- or sulphotransferases were employed to prepare glycan motifs tested with various lectins. #glycotime
www.jbc.org/article/S002...
www.jbc.org/article/S002...
November 5, 2025 at 3:20 PM
My student's paper on enzymatic remodelling to generate anionic glycan arrays has just been published online in @jbiolchem! Various recombinant glycosyl- or sulphotransferases were employed to prepare glycan motifs tested with various lectins. #glycotime
www.jbc.org/article/S002...
www.jbc.org/article/S002...
Reposted by Chris Ashwood
Establishing 18O-Labeled Inositol Phosphates for Quantitative Capillary Electrophoresis-Mass Spectrometry: Fragmentation Pathways and Comparison with 13C-Labeled Analogs #AC pubs.acs.org/doi/10.1021/...
Establishing 18O-Labeled Inositol Phosphates for Quantitative Capillary Electrophoresis-Mass Spectrometry: Fragmentation Pathways and Comparison with 13C-Labeled Analogs
Capillary electrophoresis mass spectrometry (CE-MS) allows for the rapid and accurate quantitative analysis of inositol phosphates (InsPs) and inositol pyrophosphates (PP-InsPs). The recent discovery of new InsPs and PP-InsPs isomers in plants and mammals necessitates new heavy isotope references for quantitative analysis of complex cellular extracts. Here, we evaluate 18O-labeled InsPs and PP-InsPs as alternatives to 13C labeled internal standards for quantitation by CE-MS. In contrast to 13C labels, the 18O labels are introduced at the end of a synthetic campaign and not at the beginning, rendering 18O much more accessible and affordable as a label. A series of 18O-labeled InsPs and PP-InsPs with different numbers and positions of 18O atoms were synthesized, enabling systematic investigation of MS2 fragmentation pathways. We propose two major dissociation pathways to elucidate the 18O redistribution of the dominant product ion (the loss of H3PO4). Based on these insights, we identified the loss of HPO3 as a suitable transition for minimizing isotope redistribution in MS2 analysis. The ratios of this alternative product ion and dominant product ion were reproducible across replicates, concentration, and measurement days, supporting the use of this alternative product ion as a reliable product ion for quantitative analysis. Application to Saccharomyces cerevisiae, HCT116 cells, and Arabidopsis thaliana extracts confirmed accurate quantitation and precision comparable to 13C-based methods.
pubs.acs.org
November 5, 2025 at 6:59 PM
Establishing 18O-Labeled Inositol Phosphates for Quantitative Capillary Electrophoresis-Mass Spectrometry: Fragmentation Pathways and Comparison with 13C-Labeled Analogs #AC pubs.acs.org/doi/10.1021/...
My favourite attendee feedback:
"I loved this class and I am super excited about Skyline, which is totally new to me. Halfway into the class I'm thinking "I've been living under a rock, this is going to change my life!" Without a doubt this class will have the highest ROI of anything I do this year"
"I loved this class and I am super excited about Skyline, which is totally new to me. Halfway into the class I'm thinking "I've been living under a rock, this is going to change my life!" Without a doubt this class will have the highest ROI of anything I do this year"
Wrapping up the 2025 Skyline Online Small Molecule course! Fantastic instructors and presenters, including Haley from the Baker lab with an insightful ion mobility crash course.
Great discussion and interaction from participants this year—looking forward to next year! #teammassspec
Great discussion and interaction from participants this year—looking forward to next year! #teammassspec
November 5, 2025 at 11:55 AM
My favourite attendee feedback:
"I loved this class and I am super excited about Skyline, which is totally new to me. Halfway into the class I'm thinking "I've been living under a rock, this is going to change my life!" Without a doubt this class will have the highest ROI of anything I do this year"
"I loved this class and I am super excited about Skyline, which is totally new to me. Halfway into the class I'm thinking "I've been living under a rock, this is going to change my life!" Without a doubt this class will have the highest ROI of anything I do this year"
Reposted by Chris Ashwood
What a week! So pleased to now also see the peer reviewed version in Science Signaling of @megtriesscience.bsky.social PhD work joint with the Saunders lab, see her great thread for explanation below www.science.org/doi/10.1126/...
November 4, 2025 at 8:06 PM
What a week! So pleased to now also see the peer reviewed version in Science Signaling of @megtriesscience.bsky.social PhD work joint with the Saunders lab, see her great thread for explanation below www.science.org/doi/10.1126/...
Reposted by Chris Ashwood
Check out my newest paper examining the role of the glycan-binding protein galectin-3 in placental syncytialization! We show that galectin-3 interacts with a glycan at a non-canonical N-X-C site on CD9 to promote placental cell fusion! #glycotime www.pnas.org/doi/10.1073/...
PNAS
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...
www.pnas.org
November 4, 2025 at 8:07 PM
Check out my newest paper examining the role of the glycan-binding protein galectin-3 in placental syncytialization! We show that galectin-3 interacts with a glycan at a non-canonical N-X-C site on CD9 to promote placental cell fusion! #glycotime www.pnas.org/doi/10.1073/...
Reposted by Chris Ashwood
I am delighted to share our recent collaborative progress towards drug-like glycomimetics for lectins with @anneimb.bsky.social and Roche. Published in @angewandtechemie.bsky.social #ChemBio #Glycotime onlinelibrary.wiley.com/doi/full/10....
The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA
We present Tolcapone and derivatives as a new class of potent glycomimetics for lectin inhibition. Over 3200 Roche in-house compounds were screened experimentally and a subset was biophysically evalu...
onlinelibrary.wiley.com
November 4, 2025 at 11:48 AM
I am delighted to share our recent collaborative progress towards drug-like glycomimetics for lectins with @anneimb.bsky.social and Roche. Published in @angewandtechemie.bsky.social #ChemBio #Glycotime onlinelibrary.wiley.com/doi/full/10....
“resolving power in a range of 600,000–800,000 for peptide ions across the whole m/z range, with a high repetition rate of 300 Hz (averaged to 0.5–4 Hz for enhanced dynamic range)”
Let’s see if Waters can make a big dent in the proteomics field with this
Let’s see if Waters can make a big dent in the proteomics field with this
A Novel Ultrahigh-Resolution Y-Injection Multireflecting Time-of-Flight Mass Spectrometer for Bottom-Up Proteomics #AC pubs.acs.org/doi/10.1021/...
A Novel Ultrahigh-Resolution Y-Injection Multireflecting Time-of-Flight Mass Spectrometer for Bottom-Up Proteomics
The first results of using a new type of ultrahigh-resolution mass analyzer based on a planar multipass time-of-flight mass spectrometer with periodic reflecting lenses (Y-MRT MS) for bottom-up whole-...
pubs.acs.org
November 4, 2025 at 11:20 AM
“resolving power in a range of 600,000–800,000 for peptide ions across the whole m/z range, with a high repetition rate of 300 Hz (averaged to 0.5–4 Hz for enhanced dynamic range)”
Let’s see if Waters can make a big dent in the proteomics field with this
Let’s see if Waters can make a big dent in the proteomics field with this
Reposted by Chris Ashwood
Shout out to @amgen.bsky.social rock band Sugar Box, proud to wear your merch! 😃
November 3, 2025 at 11:59 PM
Shout out to @amgen.bsky.social rock band Sugar Box, proud to wear your merch! 😃
Reposted by Chris Ashwood
Deeply honored to be a co-applicant of #BioBeyond_NL. The team will develop enabling #MassSpec based technologies to advance (glyco)proteomics, glycomics and spatial omics.
Stay tuned for PhD/post-doc openings in the near future!
www.nwo.nl/en/news/nati...
Stay tuned for PhD/post-doc openings in the near future!
www.nwo.nl/en/news/nati...
National Roadmap: NWO invests 197 million euro in eleven Large-Scale Research Infrastructures | NWO
Eleven consortia from various scientific disciplines are set to launch projects of great value to science. But also to the economic and social prosperity of the Netherlands. For example, a consortium led by TU Delft will start work on a detailed virtual model of the Dutch energy system. In another project, a consortium of UMC Utrecht is developing an MRI scanner that can scan people in motion.
www.nwo.nl
November 3, 2025 at 7:20 PM
Deeply honored to be a co-applicant of #BioBeyond_NL. The team will develop enabling #MassSpec based technologies to advance (glyco)proteomics, glycomics and spatial omics.
Stay tuned for PhD/post-doc openings in the near future!
www.nwo.nl/en/news/nati...
Stay tuned for PhD/post-doc openings in the near future!
www.nwo.nl/en/news/nati...
A popular post on LinkedIn related to the reliability of current state-of-the-art instrumentation. #teammassspec
Related, anyone know how many more scientists are employed in marketing compared to R&D?
Related, anyone know how many more scientists are employed in marketing compared to R&D?
November 3, 2025 at 7:20 AM
A popular post on LinkedIn related to the reliability of current state-of-the-art instrumentation. #teammassspec
Related, anyone know how many more scientists are employed in marketing compared to R&D?
Related, anyone know how many more scientists are employed in marketing compared to R&D?
Reposted by Chris Ashwood
www.matterworks.ai/pyxis-lsm-ms...
#massspec #metabolomics
At Matterworks have introduced a new model for metabolomics MS2 identification which is has open early access. In our hands it outperforms existing AI and traditional techniques. We would love your feedback.
#massspec #metabolomics
At Matterworks have introduced a new model for metabolomics MS2 identification which is has open early access. In our hands it outperforms existing AI and traditional techniques. We would love your feedback.
Pyxis LSM-MS2 Launch
www.matterworks.ai
November 2, 2025 at 5:20 PM
www.matterworks.ai/pyxis-lsm-ms...
#massspec #metabolomics
At Matterworks have introduced a new model for metabolomics MS2 identification which is has open early access. In our hands it outperforms existing AI and traditional techniques. We would love your feedback.
#massspec #metabolomics
At Matterworks have introduced a new model for metabolomics MS2 identification which is has open early access. In our hands it outperforms existing AI and traditional techniques. We would love your feedback.
Reposted by Chris Ashwood
Another casualty of the LLM revolution.
In "arXiv’s CS category, review articles and position papers must now be accepted at a journal or a conference and complete successful peer review."
In "arXiv’s CS category, review articles and position papers must now be accepted at a journal or a conference and complete successful peer review."
Attention Authors: Updated Practice for Review Articles and Position Papers in arXiv CS Category – arXiv blog
blog.arxiv.org
November 2, 2025 at 4:58 AM
Another casualty of the LLM revolution.
In "arXiv’s CS category, review articles and position papers must now be accepted at a journal or a conference and complete successful peer review."
In "arXiv’s CS category, review articles and position papers must now be accepted at a journal or a conference and complete successful peer review."
Reposted by Chris Ashwood
I promised myself that when I next had a successful grant, I'd share a snapshot of my trail of unfunded submissions.
With gratitude to the ARC, looking forward to next several years of collaboration on effort motivation with @minzlicht.bsky.social, Deena Skolnick Weisberg, and Frederik Anseel!
With gratitude to the ARC, looking forward to next several years of collaboration on effort motivation with @minzlicht.bsky.social, Deena Skolnick Weisberg, and Frederik Anseel!
November 2, 2025 at 2:20 AM
I promised myself that when I next had a successful grant, I'd share a snapshot of my trail of unfunded submissions.
With gratitude to the ARC, looking forward to next several years of collaboration on effort motivation with @minzlicht.bsky.social, Deena Skolnick Weisberg, and Frederik Anseel!
With gratitude to the ARC, looking forward to next several years of collaboration on effort motivation with @minzlicht.bsky.social, Deena Skolnick Weisberg, and Frederik Anseel!